Crossmark

MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner

Crossref DOI link: https://doi.org/10.1186/s13045-018-0594-4

Published Online: 2018-03-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Andriani, Francesca

Majorini, Maria Teresa

Mano, Miguel

Landoni, Elena

Miceli, Rosalba

Facchinetti, Federica

Mensah, Mavis

Fontanella, Enrico

Dugo, Matteo

Giacca, Mauro

Pastorino, Ugo

Sozzi, Gabriella

Delia, Domenico

Roz, Luca

Lecis, Daniele https://orcid.org/0000-0002-0564-0563
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (12162, 12162, 12162, 12162, IG16847)

Ministero dell’Istruzione, dell’Università e della Ricerca (RBAP11Z4Z9)
License Information

Text and Data Mining valid from 2018-03-20
More Information

Article History

Received: 28 November 2017

Accepted: 13 March 2018

First Online: 20 March 2018

Ethics approval and consent to participate

: Experiments were approved by the Independent Ethics Committee of the INT (18/12/2012 – 0016337), and informed consent was obtained from patients included in the study.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.